For Immediate Release
Chicago, IL – March 24, 2022 – The stocks in this week’s article are Meridian Bioscience, Inc. VIVO, OP Bancorp OPBK, ICU Medical, Inc. ICUI and Pangea Logistics Solutions Ltd. PANL.
Buy These 4 Low-Beta Stocks to Fight the Choppy Market
The stock market is highly volatile. Investors expect Russia’s war with Ukraine to result in continued inflation, which could drag the U.S. economy into recession. The only sign of relief is that the Federal Reserve will likely take the necessary steps to reduce inflation.
However, the US market is likely to be volatile in the near term. Therefore, creating a portfolio of low-beta stocks is paramount because the securities will deliver healthy returns and provide a shield against volatile market conditions. Four such stocks that can sail in the volatile market are Meridian Bioscience, Inc., OP Bancorp, ICU Medical, Inc. at Pangea Logistics Solutions Ltd.
Understanding Beta
Beta measures the volatility or risk of a particular asset versus the market. In other words, beta measures the extent of the price movement of a security relative to the market. In this article, we consider the S&P 500 as the market.
If a stock has a beta of 1, the price of the stock will move to the market. Thus, the stock is more volatile than the market if its beta is more than 1. In the same way, the stock is not as volatile as the market if its beta is less than 1.
For example, if the market offers a return of 20%, a stock with a beta of 3 will return 60%, which is overwhelming. Similarly, when the market slips 20%, the stock will sink 60%, which is devastating.
Here are four of the 13 stocks that qualified for screening:
Meridian Bioscienceheadquartered in Cincinnati, OH, primarily makes diagnostic test kits for gastrointestinal and respiratory infectious diseases.
For fiscal 2022 earnings per share (EPS), Meridian Bioscience has witnessed changes in estimates over the past 60 days. Year to date, Meridian Bioscience has gained 25.2% compared to the industry’s 6.7% decline.
OP Bancorp has a robust business model and serves the banking needs of professionals and businesses with small and medium -sized operations.
In 2022 and 2023, OP Bancorp is likely to see revenues growth of 10.6% and 4.3%, respectively. So far, OP Bancorp has gained 10.4% compared to the industry’s 6.4% rally.
Medical in the ICU has a solid business model and a well -known name in the development and sale of innovative medical products.
In 2022 and 2023, ICU Medical is likely to see revenue growth of 30.3% and 17.3%, respectively. Year to date, ICU Medical has gained 2.2% compared to the industry’s 6.7% decline.
Pangea Logistics Solutions generates steady cash flow and is a well-known name in providing logistics services to a wide range of industrial customers.
For 2022 earnings per share, Pangea Logistics has witnessed changes in its estimate of upward earnings over the past 30 days. Year to date, Pangea Logistics has gained 50.3% compared to 30.9% industry improvement.
You can get the remaining stocks on this list by signing up today for your 2-week free trial of the Research Wizard and start using this screen in your own trading. Plus, you can also create your own strategies and try them out first before taking an investment plunge.
The Research Wizard is a great place to start. It’s easy to use. Everything is in simple language. And it’s very intuitive. Start your Research Wizard test today. And the next time you read an economic report, open the Research Wizard, plug in your findings, and see what gems come up.
Click here to sign up for a free trial of the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/1886043/buy-these-4-low-beta-stocks-to-combat-the-choppy-market
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or sell short securities and/or hold long and/or short positions in the options mentioned in this material. An affiliated investment advisory firm may own or sell short securities and/or hold long and/or short positions in the options mentioned in this material.
About Screen of the Week
Zacks.com has created the first and best screening system on the web to have earned recognition as Money Magazine’s “#1 site for screening stocks”. But powerful screening tools are just the beginning. That’s why Zacks created the Screen of the Week to highlight profitable stock selection strategies that investors can actively use.
Strong Stocks That Should Be In the News
Many are less publicized and fly under the radar of Wall Street. They are hardly known to the general public. However, 220 Zacks Rank #1 “Strong Buys” is now formed by a stock-picking system that more than doubled the market from 1988 to 2016. Its average earnings are a stellar +25% per year. View these high potential stocks for free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under the common control of affiliated entities (including a broker-dealer and an investment advisor), which may engage in transactions involving the aforementioned securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: [email protected]
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you can choose to use in making your own investment decisions. Zacks provides information in this resource to you subject to Zacks’s “Terms and Conditions of Service” disclaimer. www.zacks.com/disclaimer.
Past performance does not guarantee future results. Inherent in any investment is the potential for losses. This material is provided for informational purposes only and does not constitute investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is given as to whether any investment is suitable for a particular investor. It should not be assumed that any investment in the securities, companies, sectors or markets defined and described will be profitable or will be profitable. All information is up to date and is subject to change without notice. Any views or opinions expressed may not reflect the views of the company as a whole. Zacks Investment Research is not engaged in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that are rebalance monthly with no transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information on the performance numbers shown in this press release.
Want the latest recommendations from Zacks Investment Research? Now, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Meridian Bioscience Inc. (VIVO): Free Stock Analysis Report
ICU Medical, Inc. (ICUI): Free Stock Analysis Report
Pangea Logistics Solutions Ltd. (PANL): Free Stock Analysis Report
OP Bancorp (OPBK): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research